Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIOK3 | O14730 | 2/20 | 0.54 |
| ▸ | SRC | P12931 | 7/20 | 0.53 |
| ▸ | ABL1 | P00519 | 2/20 | 0.49 |
| ▸ | EGFR | P00533 | 2/20 | 0.49 |
| ▸ | SYK | P43405 | 2/20 | 0.49 |
| ▸ | FLT1 | P17948 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | FYN | P06241 | 2/20 | 0.48 |
| ▸ | WEE2 | P0C1S8 | 2/20 | 0.48 |
| ▸ | WEE1 | P30291 | 2/20 | 0.48 |
| ▸ | PKMYT1 | Q99640 | 2/20 | 0.48 |
| ▸ | STK25 | O00506 | 1/20 | 0.47 |
| ▸ | CIT | O14578 | 1/20 | 0.47 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | CASK | O14936 | 1/20 | 0.47 |
| ▸ | GAK | O14976 | 1/20 | 0.47 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.47 |
| ▸ | MAP3K13 | O43283 | 1/20 | 0.47 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16618011 | 0.78 | LMNA (0.45) | RIOK3SRCABL1EGFRSYK | |
| SCHEMBL27576302 | 0.76 | KDM4E (0.49) | KDM4EALDH1A1HPGD | |
| SCHEMBL28416197 | 0.73 | SRC (0.69) | RIOK3SRCABL1EGFRSYK | |
| SCHEMBL6223729 | 0.72 | ALDH1A1 (0.67) | KDM4EALDH1A1HPGD | |
| SCHEMBL7913439 | 0.72 | KDM4E (0.60) | EGFRCLK1KDM4EALDH1A1HPGD | |
| SCHEMBL4423943 | 0.72 | EHMT2 (0.59) | EGFRFLT1KDRRETPDGFRB | |
| SCHEMBL27470171 | 0.71 | ADORA2A (0.58) | ADRA2AKDM4EALDH1A1HPGD | |
| SCHEMBL4489514 | 0.71 | WEE2 (0.71) | RIOK3SRCABL1EGFRSYK | |
| SCHEMBL27567510 | 0.71 | ADORA2A (0.47) | KDRKDM4EALDH1A1HPGD | |
| SCHEMBL7202389 | 0.70 | ALDH1A1 (0.43) | SRCEGFRFYNACHEMAP2K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150098993-A1 | COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES | CELLWORKS GROUP, INC. | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150098993-A1 | COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES | TNF, C5, IL5 | RIOK3 2820/4885SRC 1638/4885ABL1 372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.